SPRC
Scisparc Ltd
NASDAQ: SPRC · HEALTHCARE · BIOTECHNOLOGY
$8.77
-2.88% today
Updated 2026-04-30
Market cap
$4.72M
P/E ratio
0.00
P/S ratio
3.61x
EPS (TTM)
$3,156.52
Dividend yield
—
52W range
$3 – $95
Volume
0.5M
Scisparc Ltd (SPRC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.46M | $-3.18M | $-3.22M | $-1.91M | $-3.77M | $-3.78M | $-3.95M | $-2.74M | $-1.89M | $-1.32M | $-1.48M | $-4.58M | $-7.13M | $-4.70M | $-4.31M | $-5.06M | $-7.92M | $-5.89M | $-5.10M |
| Capital expenditures | $189855.00 | $47948.00 | $168321.00 | $46344.00 | $108782.00 | $38568.00 | $18736.00 | $1148.00 | $513.00 | $1024.00 | $4159.00 | $44000.00 | $17000.00 | $1000.00 | $35000.00 | $35000.00 | $4.87M | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | $204232.00 | $-44221.00 | $36980.00 | $1.14M | $326522.00 | $862000.00 | $604000.00 | $553000.00 | $91000.00 | $43000.00 | $897000.00 | $196000.00 | $569000.00 |
| Free cash flow | $-1.65M | $-3.22M | $-3.39M | $-1.96M | $-3.88M | $-3.82M | $-3.97M | $-2.74M | $-1.89M | $-1.32M | $-1.48M | $-4.62M | $-7.15M | $-4.70M | $-4.34M | $-5.10M | $-12.79M | $-5.89M | $-5.10M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |